Polypharmacy in older adults is associated with adverse drug events, cognitive and functional impairment, frailty, falls, hospital admission and death [1]. Falls arise from age-related changes compounded by intrinsic and extrinsic risk factors, and the major modifiable ones are gait and balance disorders, orthostatic hypotension, sensory impairment, medicines and environmental hazards [2]. Guidelines recommend falls prevention for people who report a fall in the previous year, are concerned about falling, or have a gait speed below 0.8 to 1 m/s [2]. Of these factors, the medication list is the one a hospital team can change before discharge.
Clinical article · Surgery and trauma, Medicines and results
Falls and polypharmacy: a structured medication review for the older patient who falls
- Written for
- Geriatricians, general physicians, residents and clinical pharmacists
- Reading time
- 7 minutes
- Published
- Updated
Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.
Key points
- Medicines are one of the few fall risk factors that can be changed within days, so every older person who falls needs a structured medication review.
- Sedatives, antidepressants, antipsychotics, opioids, antihypertensives, diuretics, glucose-lowering and anticholinergic drugs are the usual fall-risk-increasing drugs.
- Measure lying and standing blood pressure: orthostatic hypotension is common, treatable and often caused by medicines.
- Use an explicit tool such as STOPP/START or the Beers criteria, and add up the anticholinergic burden across the whole list.
- Deprescribing alone has had mixed effects on falls in trials; it works best within a multifactorial plan that includes strength and balance exercise.
- Taper rather than stop sedatives, antidepressants and opioids, change one thing at a time, and write the plan in the discharge summary.
Why medicines matter in falls
A structured review, step by step
- Build an accurate list of every prescribed, over-the-counter and herbal product, with the indication and when it was started, from the patient, family, pharmacy and primary care record.
- Measure lying and standing blood pressure, check kidney function and weight, and record the falls history and what the patient wants from treatment.
- For each medicine, check that it still has an indication, that it is helping and not harming, that the dose is right, and that its benefit will arrive in a time frame that matters given the patient's prognosis and wishes.
- Apply an explicit tool: STOPP/START, or the AGS Beers criteria, which list potentially inappropriate medicines that are best avoided by most older adults [3].
- Add up the anticholinergic burden and look for prescribing cascades, in which a new drug treats the side effect of an existing one.
- Agree priorities with the patient, change one or two things at a time, and plan follow-up.
The fall-risk-increasing drugs
| Group | Examples | Main concern |
|---|---|---|
| Benzodiazepines and Z-drugs | Diazepam, temazepam, zopiclone, zolpidem | Sedation and impaired balance; both have been studied for their association with hip fracture [5] |
| Antidepressants | Tricyclics such as amitriptyline, SSRIs, mirtazapine | Sedation, orthostatic hypotension, hyponatraemia |
| Antipsychotics | Quetiapine, risperidone, haloperidol | Sedation, parkinsonism, orthostatic hypotension |
| Opioids | Tramadol, codeine, oxycodone | Sedation and dizziness; tramadol also causes hyponatraemia and lowers the seizure threshold |
| Antihypertensives, diuretics and alpha-blockers | Amlodipine, thiazides, loop diuretics, doxazosin, tamsulosin | Orthostatic hypotension, volume depletion, hyponatraemia |
| Anticholinergic drugs | Oxybutynin, amitriptyline, chlorphenamine | Confusion, blurred vision, urinary retention [4] |
| Glucose-lowering drugs | Sulfonylureas, insulin | Hypoglycaemia |
Orthostatic hypotension
Orthostatic hypotension is common and disabling and is associated with increased morbidity and mortality; revised diagnostic criteria take account of the duration of the fall in pressure and distinguish initial and delayed forms [6]. The classic definition is a sustained fall of at least 20 mmHg systolic or 10 mmHg diastolic within three minutes of standing. Measure after several minutes lying down, and record symptoms as well as numbers.
- Review the drugs first: antihypertensives, alpha-blockers, diuretics, nitrates, tricyclics, antipsychotics and dopaminergic drugs.
- The balance of benefit and harm of antihypertensive treatment can shift with age, and reducing or stopping it is appropriate for some older people [7].
- Correct volume depletion, and look for autonomic failure in Parkinson's disease, diabetes and related conditions.
- Advise slow changes of position, adequate fluid and, where suitable, compression and head-up sleeping; drug treatment is a specialist decision.
Anticholinergic burden and sedatives
Many medicines have anticholinergic properties, and their cumulative effect, the anticholinergic burden, causes short-term effects such as dry mouth, blurred vision and urinary retention and longer-term effects including dementia, worse physical function and falls [4]. A scale such as the Anticholinergic Cognitive Burden scale makes the total visible. Common contributors are bladder antimuscarinics, tricyclic antidepressants, sedating antihistamines and some antipsychotics.
Benzodiazepine use is associated with an increased rate of hip fracture, and Z-drugs, often prescribed as an alternative, have been compared with them in a meta-analysis [5]. Neither should be regarded as safe in an older person who falls; both are candidates for gradual withdrawal, with attention to the cause of insomnia.
Does deprescribing prevent falls?
The evidence is mixed. Systematic reviews of deprescribing fall-risk-increasing drugs, and of medication review as a single intervention, have examined its effect on falls and fall-related complications with varied results across settings [8, 9]. The OPERAM trial tested structured pharmacotherapy optimisation in 2,008 hospitalised adults aged 70 or over with at least three chronic conditions and at least five long-term medicines [10], and a later analysis of the same cohort examined whether stopping fall-risk-increasing drugs reduced falls [11]. Medication review is therefore best delivered as part of a multifactorial falls plan alongside exercise targeting balance, gait and strength, which has been shown to prevent falls in older people living in the community [12].
Stopping safely, and the traps
- Taper benzodiazepines, Z-drugs, antidepressants, antipsychotics, opioids, gabapentinoids and beta-blockers rather than stopping them abruptly.
- Reduce antihypertensives one at a time, rechecking lying and standing blood pressure.
- Avoid treating each condition to its single-disease target in a frail patient.
- Do not add a drug to treat another drug's side effect without asking whether the first is still needed.
- Do not attribute falls to age without a full assessment.
- Tell the patient, family and primary care team what has changed, why, and what to report, and record it in the discharge summary so that drugs are not restarted by default.
Deprescribing decisions belong to the patient and the treating team. Local falls, delirium and medicines optimisation pathways take precedence over this summary.
How Sana Health helps
The Geriatrics and Medication Review engine presents every medicine in a table with its indication, the concern, the recommendation (continue, reduce, stop or switch) and how to taper and monitor. It applies STOPP/START or the Beers criteria by name, adds up anticholinergic burden, looks for prescribing cascades and fall-risk-increasing drugs, and sets the plan against the patient's Clinical Frailty Scale grade and stated priorities. Its falls work-up includes lying and standing blood pressure, gait, vision, cognition and bone health, and the report ends with numbered PubMed references.
Questions
How should lying and standing blood pressure be measured?
Measure after the patient has lain flat for at least five minutes, then at one and three minutes after standing, noting any symptoms. A sustained fall of 20 mmHg systolic or 10 mmHg diastolic within three minutes indicates orthostatic hypotension; some patients have a delayed fall, so continue measuring if symptoms suggest it.
Is a Z-drug safer than a benzodiazepine for an older person who falls?
No. Z-drugs such as zopiclone and zolpidem also cause sedation and impaired balance, and they have been studied alongside benzodiazepines for their association with hip fracture. Both are candidates for gradual withdrawal, with sleep hygiene and treatment of the cause of insomnia.
Does stopping medicines reduce falls?
Deprescribing on its own has shown mixed results in trials, partly because falls have many causes. It is most useful as one part of a multifactorial falls assessment, combined with strength and balance exercise, vision and footwear review, home adaptation and treatment of orthostatic hypotension.
References
- Deprescribing in older adults with polypharmacy (opens in a new tab)BMJ, 2024
- Risk Assessment and Prevention of Falls in Older Community-Dwelling Adults: A Review (opens in a new tab)JAMA, 2024
- American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults (opens in a new tab)J Am Geriatr Soc, 2019
- Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis (opens in a new tab)Age Ageing, 2023
- Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis (opens in a new tab)PLoS One, 2017
- New Horizons in orthostatic hypotension (opens in a new tab)Age Ageing, 2017
- Deprescribing antihypertensive medications in older people: a systematic review and a meta-analysis (opens in a new tab)BMC Geriatr, 2026
- Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis (opens in a new tab)BMJ Open, 2021
- Medication reviews and deprescribing as a single intervention in falls prevention: a systematic review and meta-analysis (opens in a new tab)Age Ageing, 2022
- Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial (opens in a new tab)BMJ, 2021
- Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With Polypharmacy (opens in a new tab)J Am Geriatr Soc, 2025
- Exercise for preventing falls in older people living in the community (opens in a new tab)Cochrane Database Syst Rev, 2019
Related engines
Geriatrics and Medication Review
Frailty, falls and deprescribing
Interactions, dose adjustment and monitoring
Fractures, trauma surveys and limb emergencies
Related articles
Clinical article
CYP3A4 interactions that harm patients: statins, macrolides and anticoagulants
The CYP3A4 interactions most likely to harm patients: clarithromycin with statins, calcium channel blockers, colchicine and DOACs, and how to manage each.
7 min read
Guide
From patient intake form to consultation: starting with the history already taken
How Sana Health intake forms work, from a shared link to a consultation in any engine, and how to use a patient-completed history well and safely.
5 min read
Clinical article
Acute compartment syndrome: recognising it early and getting to fasciotomy in time
How to recognise acute compartment syndrome early, when compartment pressure measurement helps, and the steps from first suspicion to urgent fasciotomy.
6 min read